90
Participants
Start Date
January 31, 2014
Primary Completion Date
October 31, 2015
Study Completion Date
October 31, 2015
Low-volume C1-esterase inhibitor
Higher-volume C1-esterase inhibitor
Low-volume placebo
Higher-volume placebo
Study Site, Budapest
Study Site, Campbelltown
Study Site, Hershey
Study Site, Chevy Chase
Study Site, Richmond
Study Site, Virginia Beach
Study Site, Madrid
Study Site, Madrid
Study Site, Pilsen
Study Site, Birmingham
Study Site, Columbus
Study Site, Toledo
Study Site, Valencia
Study Site, Hradec Králové
Study Site, Tel Litwinsky
Study Site, Tel Aviv
Study Site, Tulsa
Study Site, Dallas
Study Site, Colorado Springs
Study Site, Scottsdale
Study Site, Palermo
Study Site, Bell Gardens
Study Site, La Jolla
Study Site, Orange
Study Site, Walnut Creek
Study Site, Catania
Study Site, Lake Oswego
Study Site, Spokane
Study Site, Cluj-Napoca
Study Site, Mures
Study Site, Boston
Study Site, Cincinnati
Study Site, Hamilton
Study Site, Ottawa
Study Site, Toronto
Study Site, Québec
Study Site, Barcelona
Study Site, Brighton
Study Site, London
Lead Sponsor
CSL Behring
INDUSTRY